J. DeLuca

2.0k total citations · 1 hit paper
8 papers, 1.5k citations indexed

About

J. DeLuca is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Hepatology. According to data from OpenAlex, J. DeLuca has authored 8 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Radiation and 4 papers in Hepatology. Recurrent topics in J. DeLuca's work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Advanced Radiotherapy Techniques (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). J. DeLuca is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Advanced Radiotherapy Techniques (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). J. DeLuca collaborates with scholars based in United States. J. DeLuca's co-authors include Constantin T. Yiannoutsos, Lech Papież, Robert Timmerman, Mark D. Williams, Colleen DesRosiers, Ronald C. McGarry, Ramzi Abdulrahman, James Fletcher, Higinia R. Cárdenes and Susan M. Perkins and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

J. DeLuca

8 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer

2006 1.1k citations Robert Timmerman, Ronald C. McGarry et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. DeLuca United States	6	1.2k	962	504	325	181	8	1.5k
Ramzi Abdulrahman United States	15	1.6k 1.3×	1.3k 1.4×	750 1.5×	266 0.8×	276 1.5×	39	2.1k
Yousuke Aoki Japan	16	701 0.6×	463 0.5×	387 0.8×	308 0.9×	147 0.8×	30	982
Yohei Oku Japan	22	778 0.6×	688 0.7×	531 1.1×	498 1.5×	164 0.9×	43	1.3k
Merete Paludan Denmark	9	987 0.8×	804 0.8×	466 0.9×	107 0.3×	228 1.3×	13	1.3k
Kotaro Gomi Japan	12	1.9k 1.6×	1.3k 1.4×	806 1.6×	173 0.5×	299 1.7×	18	2.2k
Anders Traberg Denmark	7	873 0.7×	717 0.7×	423 0.8×	116 0.4×	120 0.7×	7	1.2k
Joern Wulf Germany	12	953 0.8×	1.1k 1.1×	605 1.2×	237 0.7×	221 1.2×	16	1.3k
Masaharu Fujino Japan	10	1.5k 1.3×	1.3k 1.3×	875 1.7×	127 0.4×	124 0.7×	12	1.8k
Yoshiki Norihisa Japan	17	1.4k 1.1×	1.2k 1.2×	733 1.5×	120 0.4×	161 0.9×	44	1.7k
Lena Wittgren Sweden	11	1.1k 0.9×	933 1.0×	658 1.3×	102 0.3×	99 0.5×	13	1.4k

Countries citing papers authored by J. DeLuca

Since Specialization

Citations

This map shows the geographic impact of J. DeLuca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. DeLuca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. DeLuca more than expected).

Fields of papers citing papers by J. DeLuca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. DeLuca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. DeLuca. The network helps show where J. DeLuca may publish in the future.

Co-authorship network of co-authors of J. DeLuca

This figure shows the co-authorship network connecting the top 25 collaborators of J. DeLuca. A scholar is included among the top collaborators of J. DeLuca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. DeLuca. J. DeLuca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Chiorean, E. Gabriela, Bryan P. Schneider, Fatih Akisik, et al.. (2014). Phase 1 Pharmacogenetic and Pharmacodynamic Study of Sorafenib With Concurrent Radiation Therapy and Gemcitabine in Locally Advanced Unresectable Pancreatic Cancer. International Journal of Radiation Oncology*Biology*Physics. 89(2). 284–291. 26 indexed citations

2.

Varlotto, John M., Achilles J. Fakiris, John C. Flíckinger, et al.. (2013). Matched‐pair and propensity score comparisons of outcomes of patients with clinical stage I non–small cell lung cancer treated with resection or stereotactic radiosurgery. Cancer. 119(15). 2683–2691. 80 indexed citations

3.

Shelkey, Julia, Achilles J. Fakiris, Malcolm M. DeCamp, et al.. (2012). Matched-pair comparison of outcome of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery.. Journal of Clinical Oncology. 30(15_suppl). 7040–7040. 3 indexed citations

4.

Cárdenes, Higinia R., T R Price, Susan M. Perkins, et al.. (2010). Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. Clinical & Translational Oncology. 12(3). 218–225. 233 indexed citations

5.

Cárdenes, Higinia R., T R Price, Susan M. Perkins, et al.. (2008). Phase I Trial of Stereotactic Body Radiation Therapy for Primary Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 72(1). S128–S129. 5 indexed citations

6.

Henderson, M., et al.. (2007). Preliminary Toxicity Analysis of a Phase I/II Trial Evaluating Stereotactic Body Radiotherapy for the Treatment of Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 69(3). S297–S297. 2 indexed citations

7.

Timmerman, Robert, Ronald C. McGarry, Constantin T. Yiannoutsos, et al.. (2006). Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer. Journal of Clinical Oncology. 24(30). 4833–4839. 1127 indexed citations breakdown →

8.

Timmerman, Robert, R.C. McGarry, Lech Papież, et al.. (2005). Initial Report of a Prospective Phase II Trial of Stereotactic Body Radiation Therapy for Patients with Medically Inoperable Stage I Non-small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 63. S99–S99. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact